Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot-dissolving agent, for the ...
Trident Medical Center is nearing completion of a brand-new Neuro Rehabilitation Unit. Leaders with the hospital saw a need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback